Mixed news on COVID19 vaccines: COVID-19 R&D tracker
Life Sciences Research & Analysis Mixed news on COVID19 vaccines: COVID-19 R&D tracker 26 October 2020 Gustav Ando In the latest edition of...
Mr. Ando oversees the development of IHS Markit's global healthcare outlook analysis that focuses on market access, cost of healthcare and new treatment advances as well as coordinating its ongoing thinking on COVID-19. He heads the research and data teams that produce daily analysis, risk assessment and critical data for the pharmaceutical industry, as well as the consulting team that focuses on disease prevention, workforce and demand healthcare microsimulation models. With more than 15 years of experience in the industry, he is a regular speaker at conferences and is frequently cited by major media publications and national radio and television programs. He is the author and podium presenter of research at numerous academic conferences such as ISPOR. Mr Ando also oversees our global comparative industry group which provide critical long-term forecast perspectives across all industries around the world, as well as our specialised global constructrion group. Mr. Ando holds a postgraduate degree from the University of Uppsala, Sweden, and an undergraduate degree from the University of Durham in the United Kingdom.
Join our IHS Markit experts, including Chief Econo (...)
Secrets to Surviving in Volatility: Planning for s (...)
Following the executive order on 13 September to l (...)